Agreed, current management and BOD has no skin in the game, they would prefer to just keep going on the same path, enriching themselves with free shares, hoping things turn around in Europe. If not, so what they already milked the starving cow if it dies they just eat steak and move on. The arrogance they show continuing to think they can make this company grow with one drug in a market that continues to evaporate daily is beyond astonishing. I am all in with Denner as it is the only hope, in my opinion, to get any return on this investment. I have been here 11 years and I am beyond exhausted.